Lee GW - Search Results

1

Lazertinib versus Gefitinib as First-Line Treatment for EGFR-mutated Locally Advanced or Metastatic NSCLC: LASER301 Korean Subset.

Lee KH, Cho BC, Ahn MJ, Lee YG, Lee Y, Lee JS, Kim JH, Min YJ, Lee GW, Lee SS, Lee KH, Ko YH, Shim BY, Kim SW, Shin SW, Choi JH, Kim DW, Cho EK, Park KU, Kim JS, Chun SH, Wang J, Choi S, Kang JH. Lee KH, et al. Among authors: lee y, lee js, lee yg, lee gw, lee ss. Cancer Res Treat. 2024 Jan;56(1):48-60. doi: 10.4143/crt.2023.453. Epub 2023 Jun 27. Cancer Res Treat. 2024. PMID: 37402411 Free PMC article. Clinical Trial.

2

Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma.

Lee GW, Kang JH, Kim HG, Lee JS, Lee JS, Jang JS. Lee GW, et al. Among authors: lee js. Am J Clin Oncol. 2006 Apr;29(2):127-31. doi: 10.1097/01.coc.0000203742.22828.bb. Am J Clin Oncol. 2006. PMID: 16601429 Clinical Trial.

3

Combination chemotherapy with irinotecan and cisplatin in elderly patients (>or= 65 years) with extensive-disease small-cell lung cancer.

Kim HG, Lee GW, Kang JH, Kang MH, Hwang IG, Kim SH, Hahm JR, Jeong YY, Kim HC, Lee JD, Lee JS, Hwang YS. Kim HG, et al. Among authors: lee js, lee jd, lee gw. Lung Cancer. 2008 Aug;61(2):220-6. doi: 10.1016/j.lungcan.2007.12.020. Epub 2008 Feb 12. Lung Cancer. 2008. PMID: 18272249 Clinical Trial.

4

Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer.

Lee GW, Kang MH, Kim HG, Kang JH, Kim SH, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim HJ, Lee JS. Lee GW, et al. Among authors: lee js, lee jd. Cancer Chemother Pharmacol. 2009 Jul;64(2):385-90. doi: 10.1007/s00280-008-0885-5. Epub 2008 Dec 23. Cancer Chemother Pharmacol. 2009. PMID: 19104817

5

High-dose chemotherapy of cyclophosphamide, thiotepa and carboplatin (CTCb) followed by autologous stem-cell transplantation as a consolidation for breast cancer patients with 10 or more positive lymph nodes: a 5-year follow-up results.

Sohn HJ, Kim SH, Lee GW, Kim S, Ahn JH, Kim SB, Kim SW, Kim WK, Suh C. Sohn HJ, et al. Among authors: lee gw. Cancer Res Treat. 2005 Jun;37(3):137-42. doi: 10.4143/crt.2005.37.3.137. Epub 2005 Jun 30. Cancer Res Treat. 2005. PMID: 19956494 Free PMC article.

6

High-dose chemotherapy of cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by autologous stem-cell transplantation for metastatic breast cancer patients: a 6-year follow-up result.

Sohn HJ, Kim SH, Lee GW, Kim S, Kang HJ, Ahn JH, Kim SB, Kim SW, Kim WK, Suh C. Sohn HJ, et al. Among authors: lee gw. Cancer Res Treat. 2005 Feb;37(1):24-30. doi: 10.4143/crt.2005.37.1.24. Epub 2005 Feb 28. Cancer Res Treat. 2005. PMID: 19956506 Free PMC article.

7

A phase II trial of haptaplatin/5-FU and leucovorin for advanced stomach cancer.

Lee WS, Lee GW, Kim HW, Lee OJ, Lee YJ, Ko GH, Lee JS, Jang JS, Ha WS. Lee WS, et al. Among authors: lee js, lee oj, lee yj, lee gw. Cancer Res Treat. 2005 Aug;37(4):208-11. doi: 10.4143/crt.2005.37.4.208. Epub 2005 Aug 31. Cancer Res Treat. 2005. PMID: 19956515 Free PMC article.

8

A phase II trial of docetaxel and ifosfamide for patients with platinum-resistant or refractory non-small cell lung cancer in a salvage setting.

Lee GW, Kang JH, Kim SH, Lee HY, Kim HC, Lee WS, Lee JD, Hwang YS, Jang JS, Lee JS. Lee GW, et al. Among authors: lee js, lee jd, lee ws, lee hy. Cancer Res Treat. 2004 Oct;36(5):287-92. doi: 10.4143/crt.2004.36.5.287. Epub 2004 Oct 31. Cancer Res Treat. 2004. PMID: 20368817 Free PMC article.

9

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia.

Lee JH, Joo YD, Kim H, Bae SH, Kim MK, Zang DY, Lee JL, Lee GW, Lee JH, Park JH, Kim DY, Lee WS, Ryoo HM, Hyun MS, Kim HJ, Min YJ, Jang YE, Lee KH; Cooperative Study Group A for Hematology. Lee JH, et al. Among authors: lee kh, lee ws, lee gw, lee jl. Blood. 2011 Oct 6;118(14):3832-41. doi: 10.1182/blood-2011-06-361410. Epub 2011 Aug 9. Blood. 2011. PMID: 21828126 Free article. Clinical Trial.

10

Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine.

Lee JH, Joo YD, Kim H, Ryoo HM, Kim MK, Lee GW, Lee JH, Lee WS, Park JH, Bae SH, Hyun MS, Kim DY, Kim SD, Min YJ, Lee KH. Lee JH, et al. Among authors: lee kh, lee ws, lee gw. J Clin Oncol. 2013 Feb 20;31(6):701-9. doi: 10.1200/JCO.2011.40.2362. Epub 2012 Nov 5. J Clin Oncol. 2013. PMID: 23129746 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

699 results

Search Page